Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Nutrien ( (TSE:NTR) ) is now available.
Nutrien reported full-year 2025 net earnings of $2.30 billion and adjusted EBITDA of $6.05 billion, driven by higher fertilizer selling prices, record upstream sales volumes and stronger retail performance, while fourth-quarter net earnings reached $0.58 billion. The company highlighted significant free cash flow generation, about $900 million in asset sale proceeds since late 2024, reduced adjusted net debt and a 30 percent increase in cash returns to shareholders through dividends and buybacks.
Retail adjusted EBITDA rose to $1.74 billion in 2025 as cost savings, stronger proprietary product margins and a disciplined Brazil strategy improved profitability. Potash adjusted EBITDA climbed to $2.25 billion on higher prices and record volumes, supported by strong affordability and demand, while automation accounted for nearly half of mined ore tonnes, reinforcing Nutrien’s low-cost edge.
Nitrogen adjusted EBITDA increased to $2.15 billion as operating rates improved and low-cost debottlenecking projects at North American plants expanded ammonia output. The board approved a modest dividend increase to $0.55 per share and authorized a new normal course issuer bid for up to 5 percent of outstanding shares, subject to exchange approval, signaling continued focus on shareholder returns.
Strategic portfolio actions continued, including the $0.6 billion sale of Nutrien’s 50 percent stake in Profertil S.A. and the cessation of production at the New Madrid nitrogen upgrade facility, both aimed at concentrating on core, higher-return assets. The company is also reviewing strategic alternatives for its phosphate business and assessing options for its Trinidad nitrogen facility, positioning the portfolio for enhanced earnings quality, capital efficiency and resilience as it pursues 2026 performance targets and benefits from supportive potash and nitrogen market fundamentals.
The most recent analyst rating on (TSE:NTR) stock is a Buy with a C$80.00 price target. To see the full list of analyst forecasts on Nutrien stock, see the TSE:NTR Stock Forecast page.
Spark’s Take on TSE:NTR Stock
According to Spark, TipRanks’ AI Analyst, TSE:NTR is a Outperform.
Nutrien’s overall stock score reflects strong financial performance and positive technical indicators. The company’s strategic initiatives and market outlook are promising, though operational challenges in specific segments pose some risks. The valuation is attractive, supported by a reasonable P/E ratio and a solid dividend yield.
To see Spark’s full report on TSE:NTR stock, click here.
More about Nutrien
Nutrien Ltd., listed on the TSX and NYSE under the ticker NTR, is a major North American fertilizer and agricultural retail company. It operates upstream potash and nitrogen production assets alongside a global retail network, with a strategic focus on low-cost fertilizer production, portfolio optimization and growing higher-margin retail earnings, including in key markets such as Brazil and offshore potash destinations.
Average Trading Volume: 1,929,654
Technical Sentiment Signal: Buy
Current Market Cap: C$46.63B
See more data about NTR stock on TipRanks’ Stock Analysis page.